XML 31 R1.htm IDEA: XBRL DOCUMENT v3.25.1
Document and Entity Information - USD ($)
 12 Months Ended
Dec. 31, 2024
Mar. 24, 2025
Jun. 30, 2024
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Period End Date Dec. 31, 2024    
Document Fiscal Year Focus 2024    
Document Fiscal Period Focus FY    
Document Annual Report true    
Document Transition Report false    
Entity Registrant Name Biomea Fusion, Inc.    
Entity Central Index Key 0001840439    
Current Fiscal Year End Date --12-31    
Entity Filer Category Non-accelerated Filer    
Trading Symbol BMEA    
Entity Emerging Growth Company true    
Entity Ex Transition Period false    
Entity Small Business true    
Entity Common Stock, Shares Outstanding   37,572,250  
Entity Public Float     $ 124,145,240
Entity Interactive Data Current Yes    
Title of 12(b) Security Common Stock, $0.0001 par value    
Security Exchange Name NASDAQ    
Entity Current Reporting Status Yes    
Entity Shell Company false    
Entity File Number 001-40335    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 82-2520134    
Entity Address, Address Line One 900 Middlefield Road, 4th Floor    
Entity Address, City or Town Redwood City    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 94063    
City Area Code 650    
Local Phone Number 980-9099    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Auditor Firm ID 34    
Auditor Name Deloitte & Touche LLP    
Auditor Location San Francisco, CA    
Auditor Opinion [Text Block]

Opinion on the Financial Statements

 

We have audited the accompanying balance sheets of Biomea Fusion, Inc. (the “Company”) as of December 31, 2024 and 2023, the related statements of operations and comprehensive loss, stockholders’ equity (deficit), and cash flows, for each of the three years in the period ended December 31, 2024, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America.

    
Documents Incorporated by Reference

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the Registrant’s definitive proxy statement to be filed with the Securities and Exchange Commission, or SEC, on or before the date 120 days after the conclusion of the Registrant’s fiscal year ended December 31, 2024 pursuant to Regulation 14A in connection with the Registrant’s 2025 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K.